Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 4Phase 1/2 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Glioblastoma 6Breast Neoplasms 4Neoplasm Metastasis 3Glioma 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neoplasms 2Gliosarcoma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Brain Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Rectal Neoplasms 1Pinealoma 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Meningioma 1Medulloblastoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1

Interventions

Gemcitabine 15pembrolizumab 13Doxorubicin 13Radiotherapy 12Docetaxel 9Nivolumab 8Filgrastim 7Cyclophosphamide 7pazopanib 6Ifosfamide 6130-nm albumin-bound paclitaxel 5Temozolomide 4Irinotecan 4Ipilimumab 4Imatinib Mesylate 4Albumin-Bound Paclitaxel 4talimogene laherparepvec 3surufatinib 3pegfilgrastim 3eribulin 3atezolizumab 3Vinorelbine 3Sirolimus 3Peripheral Blood Stem Cell Transplantation 3PM 01183 3Drug Therapy 3Cisplatin 3toripalimab 2spartalizumab 2selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Sarcoma × Surgical Procedures, Operative × Clear all
NCT03116529 2024-11-04

NEXIS

University of Maryland, Baltimore

Phase 1/2 Terminated
22 enrolled
Sarcoma

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Sarcoma

NCT02496520 2020-02-21

DEND/TIA

Clinica Universidad de Navarra, Universidad de Navarra

Phase 1/2 Completed
6 enrolled
CNSSarcoma

Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡